IUPHAR review: From foe to friend: Repurposing glucagon to treat obesity and type 2 diabetes
The epidemics of metabolic disease, in the form of obesity and type 2 diabetes, are a growing public health concern. However, incretin-based therapeutics have transformed our ability to address these diseases. While this current generation of incretin analogues show weight regain upon cessation of t...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2026-01-01
|
| Serier: | Pharmacological Research |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S104366182500502X |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
